Application of mirtazapine in management of side effects of psychotropic drugs

doi:10.3877/cma.j.issn.1674-0785.2017.15.008

Abstract

Abstract:

Mirtazapine is a noradrenergic and specific serotonergic antidepressant, and it has been used to manage the side effects of many psychotropic drugs. This paper reviews the application of mirtazapine in the management of antipsychotic-induced akathisia, selective serotonin reuptake inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone, hyperhidrosis, nausea, vomiting, urinary retention, paroxetine-induced hyper-prolactinemic galactorrhoea, psychotropic drug-induced sexual dysfunction, and clozapine-induced sialorrhea, as well as in aiding benzodiazepine withdrawal.

Key words: Mirtazapine, Psychotropic drug-induced side effects, Progress

Xiangfen Yu, Yuxin Sun, Zhenxiao Sun. Application of mirtazapine in management of side effects of psychotropic drugs[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(15): 2097-2100.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2017.15.008

https://zhlcyszz.cma-cmc.com.cn/EN/Y2017/V11/I15/2097

References 30

[1]	孙振晓，于相芬，孙波. 米氮平的临床应用及其不良反应 [J]. 精神医学杂志, 2012, 25(4):310-313.
[2]	Poyurovsky M, Weizman A. Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem [J]. Br J Psychiatry, 2001, 179(1):4-8.
[3]	于相芬，孙振晓，孙波. 抗精神病药物所致急性静坐不能的研究现状 [J]. 中国执业药师, 2012, 9(4):32-38.
[4]	Poyurovsky M. Acute antipsychotic-induced akathisia revisited [J]. Br J Psychaitry, 2010, 196(2):89-91.
[5]	Poyurovsky M, Weizman A. Mirtazapine for neuroleptic-induced akathisia [J]. Am J Psychiatry, 2001, 158(5):819.
[6]	Poyurovsky M, Bergman J, Pashinian A, et al. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia [J]. Int Clin Psychopharmacol, 2014, 29(5):296-298.
[7]	Hieber R, Dellenbaugh T, Nelson LA. Role of mirtazapine in the treatment of antipsychotic-induced akathisia [J]. Ann Pharmacother, 2008, 42(6):841-846.
[8]	Praharaj SK, Kongasseri S, Behere RV, et al. Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials [J]. Ther Adv Psychopharmacol, 2015, 5(5):307-313.
[9]	Koufakis T. Quetiapine-induced syndrome of inappropriate secretion of antidiuretic hormone [J]. Case Rep Psychiatry, 2016, 2016:4803132.
[10]	Jagsch C, Marksteiner J, Seiringer E, et al. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion [J]. Pharmacopsychiatry, 2007, 40(3):129-131.
[11]	Mogi T, Yoshino A, Ikemoto G, et al. Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone [J]. Psychiatry Clin Neurosci, 2012, 66(1):80.
[12]	孙振晓，于相芬. 抗抑郁剂所致多汗症的研究现状 [J]. 中国执业药师, 2013, 10(12):23-25, 38.
[13]	Buecking A, Vandeleur CL, Khazaal Y, et al. Mirtazapine in drug-induced excessive sweating [J]. Eur J Clin Pharmacol, 2005, 61(7):543-544.
[14]	Edwards JG, Anderson I. Systematic review and guide to selelection of selective serotonin reuptake inhibitors [J]. Drugs, 1999, 57(4):507-533.
[15]	Caldis EV, Gair RD. Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors [J]. Can J Psychiatry, 2004, 49(10):707.
[16]	喻东山，葛茂宏，苏海陵. 精神科合理用药手册[M]. 3版. 南京: 江苏凤凰科学技术出版社, 2016: 270.
[17]	Lenze EJ. Reversal of SSRI-associated urinary retention with mirtazapine augmentation [J]. J Clin Psychopharmacol, 2012, 32(3):434.
[18]	Chatterjee SS, Mitra S, Mallik N. Emerging hyperprolactinemic galactorrhea in obsessive compulsive disorder with a stable dose of Fluoxetine [J]. Clin Psychopharmacol Neurosci, 2015, 13(3):316-318.
[19]	Stahl S. Stahl′s essential psychopharmacology: neuroscientific basis and practical application [M]. 4th ed. Cambridge: Cambridge University Press, 2013: 298-318.
[20]	Singh M, Anwar Z, Sinha V, et al. Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea [J]. Clin Psychopharmacol Neurosci, 2015, 13(2):222-223.
[21]	Fava M, Rankin M. Sexual functioning and SSRIs [J]. J Clin Psychiatry, 2002, 63(S5):25-30.
[22]	Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer anti- depressants [J]. J Clin Psychiatry, 2002, 63(4):357-366.
[23]	Khawam EA, Laurencic G, Malone JR. Side effects of antidepressants: An overview [J]. Cleveland Clin J Med, 2006, 73(4):351-361.
[24]	Atmaca M, Korkmaz S, Topuz M, et al. Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation [J]. Psychiatry Investig, 2011, 8(1):55-57.
[25]	Gelenberg AJ, McGahuey C, Laukes C, et al. Mirtazapine substitution in SSRI-induced sexual dysfunction [J]. J Clin Psychiatry, 2000, 61(5):356-360.
[26]	Ozmenler NK, Karlidere T, Bozkurt A, et al. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors [J]. Hum Psychopharmacol, 2008, 23(4):321-326.
[27]	Terevnikov V, Stenberg JH, Tiihonen J, et al. Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics [J]. Nord J Psychiatry, 2017, 71(1):77-80.
[28]	Glick AR, Khan IA, Sher L. Treatment of antipsychotic-induced sialorrhea [J]. Psychiat Ann, 2014, 44(6):267-269.
[29]	张荣华，季建林. 苯二氮卓类药物的依赖及戒断 [J]. 国外医学(精神病学分册), 2005, 32(2):82-85.
[30]	Chandrasekaran PK. Employing mirtazapine to aid benzodiazepine withdrawal [J]. Singapore Med J, 2008, 49(6):e166-167.

Please choose a citation manager

Content to export